Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Nicole Engen et al.|The Lancet Respiratory Medicine|2022Cited by 127
Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumoniaBijan Safaee Fakhr, Robert M. Kacmarek, Raffaele Di Fenza et al.|Nitric Oxide|2021Cited by 68